Related Experiment Videos
Lymphocytic hypophysitis successfully treated with azathioprine: first case report
A Lecube1, G Francisco, D Rodríguez
1Division of Endocrinology, Hospital Vall d'Hebron, Barcelona, Spain.
Journal of Neurology, Neurosurgery, and Psychiatry
|November 18, 2003
Summary
Azathioprine effectively treated aggressive lymphocytic hypophysitis when corticosteroids failed. This study presents the first evidence of azathioprine
Area of Science:
- Endocrinology
- Neurology
- Immunology
Background:
- Lymphocytic hypophysitis is a rare inflammatory condition affecting the pituitary gland.
- Corticosteroids are the typical first-line treatment, but efficacy can be limited.
Observation:
- A 53-year-old patient presented with headache, diplopia, and diabetes insipidus due to an intrasellar/suprasellar mass.
- Initial treatment with prednisone provided temporary relief, but symptoms recurred upon dose reduction.
Findings:
- Despite surgery and high-dose methylprednisolone for aseptic meningoencephalitis, the mass progressed.
- Azathioprine treatment led to complete radiological and clinical remission within four weeks.
- The patient remained disease-free for 18 months post-azathioprine cessation.
Implications:
- Azathioprine represents a novel and effective therapeutic option for refractory lymphocytic hypophysitis.
- This finding expands treatment strategies for this challenging pituitary disorder.
- Further research is warranted to confirm azathioprine's efficacy in a larger cohort.